Cervicogenic Headache, Cognitive Dysfunction

Cervicogenic Headache Clinical Trial

Official title:

Frequency of Cognitive Dysfunction in Individuals With Cervicogenic Headache

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05572489
• Other study ID #: 2021-01-02
• Status: Recruiting
• Start date: January 1, 2022
• Est. completion date: January 1, 2023

Study information

• Verified date: October 2022
• Source: Konya Beyhekim Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The goal of this study was to determine the frequency of cognitive dysfunction in patients with cervicogenic headache. participants will be asked questions to determine their cognitive status at once.

Description:

A set of survey-type questions will be asked to the participants. Pain and fatigue levels of the patients were measured by visual pain scale (VAS), mood states by Beck depression scale (BDI) and Pain catastrophizing scale (Pain catastrophizing scale), quality of life by Short Form-36 (SF-36), and cognitive status by Standard Mini. mental test (SMMT) and Montreal cognitive assessment scale (MOCA).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: January 1, 2023
• Est. primary completion date: December 1, 2022
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

Clinical Diagnosis of cervicogenic headache be over 18 Exclusion Criteria: those under the age of 18 Those with neurological deficits Those with rheumatic diseases such as fibromyalgia, polymyalgia rheumatica, ankylosing spondylitis, rheumatoid arthritis Surgery in the cervical region in the past 6 months Those with widespread pain, significant pain in another anatomical location (eg, gonarthrosis) Those who use drugs or substances (alcohol, drugs, etc.) that may cause cognitive impairment Those with known neurological diseases such as cerebrovascular disease, MS, Parkinson's, dementia Those with major psychiatric illness Those with communication problems Those who have started psychiatric medical treatment in the last three months Those with significant hearing or vision problems Those with a history of uncontrollable systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological, endocrine..)

Related Conditions & MeSH terms

• Cervicogenic Headache
• Cognitive Dysfunction
• Headache
• Post-Traumatic Headache

Intervention

Diagnostic Test:
• visual pain scale Beck depression scale Pain catastrophizing scale Short Form-36 Standard Mini mental test Montreal cognitive assessment scale
evaluation of pain, fatigue, mood, quality of life, cognitive status

Locations

Country	Name	City	State
Turkey	Konya Beyhekim Research and Training Hospital	Konya	Selçuklu

Sponsors (1)

Lead Sponsor	Collaborator
Konya Beyhekim Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol. 2009 Oct;8(10):959-68. doi: 10.1016/S1474-4422(09)70209-1. Review. — View Citation

Sjaastad O. Cervicogenic headache: comparison with migraine without aura; Vågå study. Cephalalgia. 2008 Jul;28 Suppl 1:18-20. doi: 10.1111/j.1468-2982.2008.01610.x. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	cognitive status		01.12.2022